会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING HISTONE H1
    • 诊断,预防和治疗精神分裂症及其临床亚型,使用HISTONE H1
    • WO1997038713A1
    • 1997-10-23
    • PCT/US1997006987
    • 1997-04-11
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIACEDARS-SINAI MEDICAL CENTER
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIACEDARS-SINAI MEDICAL CENTERBRAUN, JonathanTARGAN, Stephan, R.EGGENA, Mark
    • A61K39/00
    • G01N33/564A61K39/0008
    • The present invention provides a method of diagnosing ulcerative colitis (UC) in a subject suspected of having inflammatory bowel disease by obtaining a sample from the individual; contacting the sample with human histone H1, or pANCA-reactive fragment thereof, under conditions suitable to form a complex of human histone H1, or pANCA-reactive fragment thereof, and antibody to human histone H1; and detecting the presence or absence of the complex, where the presence of the complex indicates that the individual has UC. The invention also provides related methods of diagnosing a perinuclear anti-neutrophil cytoplasmic antibody positive (pANCA-positive) clinical subtype of UC in a patient with UC. In addition, the invention further provides methods of determining susceptibility to UC in an individual. The invention further provides methods of inducing tolerance in a pANCA-positive patient with UC by administering an effective dose of histone H1, or tolerogenic fragment thereof, to the pANCA-positive patient with UC. Compositions of histone H1, or fragment thereof, combined with a tolerogizing molecule also are provided.
    • 本发明提供一种通过从个体获得样品来诊断疑似患有炎症性肠病的受试者的溃疡性结肠炎(UC)的方法; 在适于形成人组蛋白H1或其pANCA反应性片段的复合物和人组蛋白H1的抗体的条件下,将样品与人组蛋白H1或其pANCA反应性片段接触; 并检测复合物的存在或不存在,其中复合物的存在表明个体具有UC。 本发明还提供了在UC患者中诊断UC的核周抗中性粒细胞胞质抗体阳性(pANCA阳性)临床亚型的相关方法。 此外,本发明还提供了确定个体对UC的易感性的方法。 本发明进一步提供了通过向具有UC的pANCA阳性患者施用有效剂量的组蛋白H1或其耐受性片段来诱导具有UC的pANCA阳性患者的耐受性的方法。 还提供组蛋白H1或其片段的组合物与耐受性分子组合。
    • 5. 发明申请
    • METHOD OF ALLEVIATING NEUROPATHIC PAIN
    • 治疗神经痛疼痛的方法
    • WO1998039357A1
    • 1998-09-11
    • PCT/US1997016062
    • 1997-09-11
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    • THE REGENTS OF THE UNIVERSITY OF CALIFORNIAO'BRIEN, John, S.
    • C07K04/00
    • C07K14/475A61K38/00
    • The invention provides a method of alleviating neuropathic pain in a subject by administering a neuropathic pain alleviating amount of prosaposin receptor agonist to the subject. The invention also provides a method of inhibiting the onset of neuropathic pain in a subject by administering neuropathic pain alleviating amount of prosaposin receptor agonist to the subject. The present invention also provides prosaposin receptor agonists and the use of these agonists for stimulating neurite outgrowth, inhibiting neural cell death, promoting myelination and inhibiting neural demyelination. In addition, there is provided a method of inhibiting sensory or motor neuropathy by contacting neuronal cells with a composition comprising an effective inhibiting amount of prosaposin receptor agonist.
    • 本发明提供了一种减轻受试者神经性疼痛的方法,该方法是通过对受试者施用神经性疼痛缓解量的prosaposin受体激动剂。 本发明还提供一种抑制受试者神经性疼痛发作的方法,该方法是向受试者施用神经性疼痛缓解量的prosaposin受体激动剂。 本发明还提供了prosaposin受体激动剂和这些激动剂用于刺激神经突生长,抑制神经细胞死亡,促进髓鞘形成和抑制神经脱髓鞘的用途。 此外,提供了通过使神经元细胞与包含有效抑制量的前列腺素受体激动剂的组合物接触来抑制感觉或运动神经病的方法。